The EXPERTS Act of 2025 amends 5 U.S.C. §553 and related statutes to require expanded disclosure of funding, review, and financial ties for scientific, economic, and technical studies submitted to agencies during rulemakings. It directs agencies to post submitted studies publicly (subject to FOIA exemptions), mandates public notice when submissions present a conflict, and authorizes agencies to exclude submissions that fail to include required disclosures.
Beyond disclosure, the bill creates an Office of the Public Advocate in OMB to boost public participation and conduct social equity assessments, narrows negotiated rulemaking to intergovernmental negotiations, sets firm OIRA review timelines (60 days plus a single 30‑day extension), establishes civil penalties for SEC-reporting companies that submit knowingly false material, and lengthens the window for judicial review to six years. These changes are designed to increase transparency and make the administrative record around significant rules more traceable — with practical consequences for agencies, regulated industries, research sponsors, and public-interest groups.
At a Glance
What It Does
Amends 5 U.S.C. §553 to require detailed disclosures when an interested person submits non‑peer‑reviewed scientific, economic, or technical work to an agency; requires agencies to publish those materials and to flag conflicts of interest meeting statutory tests. The bill also creates an OMB Office of the Public Advocate, shortens OIRA review windows, and adds civil penalties for public companies that knowingly file false submissions.
Who It Affects
Federal agencies, OMB/OIRA, public companies that file SEC reports, think tanks and consultants that fund or produce regulatory studies, academic researchers retained by interested parties, and community groups targeted for increased outreach and social‑equity assessments.
Why It Matters
It changes the evidentiary and procedural landscape of rulemaking by turning many external studies into disclosure‑laden, docketed materials and by creating a federal office whose mission is to expand participation and assess equity — shifts that affect how agencies build, defend, and publish regulatory records.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill revises the standard notice-and-comment framework by adding concrete disclosure obligations for “interested persons” who submit studies to an agency docket. If a submission contains scientific, economic, or technical research that the submitter funded or commissioned and that is not published in a publicly available peer‑reviewed journal, the submitter must disclose funding sources, sponsoring entities, any third parties that reviewed or revised the work, and the nature of financial relationships between authors and parties affected by the rule.
Agencies must make such materials available on their public docket unless exempted under FOIA (section 552).
The statute defines a reportable conflict and requires agencies to publicly flag conflicts on their websites, dockets, and in the Federal Register where (a) at least 10 percent of study funding comes from an entity subject to the agency’s jurisdiction for that rulemaking, or (b) an entity regulated by the agency conducted, reviewed, or revised the research. Agencies may exclude or disregard submissions that fail to comply with the disclosure rules, although a submitter may resubmit the material with the required disclosures during the open comment period.Procedural reforms run in parallel.
The bill establishes an Office of the Public Advocate in OMB — a Senate‑confirmed official — charged with expanding outreach, helping underserved communities participate in rulemakings, developing cross‑government social equity definitions, and producing social equity assessments on request within 30 days. The statute also narrows “negotiated rulemaking” to processes between governments (Federal, State, local, Tribal) rather than broad stakeholder negotiation, and creates explicit duties to record changes an agency made after sharing drafts with OMB (the Office) and whether such changes resulted from communications with OMB or other federal officials.Other mechanics: OIRA must complete reviews of significant regulatory actions within 60 days, with a single available 30‑day extension (public justification required).
Agencies may reinstate rules previously disapproved by joint resolutions within one year of the Act’s enactment. The bill imposes minimum civil penalties ($250,000 for a first violation, $1,000,000 for subsequent violations) on entities subject to SEC annual reporting that knowingly submit materially false or misleading information in rulemaking comments, and it creates a six‑year statute of limitations for judicial review of final agency action.
Finally, the bill requires agencies to expand public notice and create participation logs, and it requires agencies to respond within 60 days to petitions that receive more than 100,000 signatures.
The Five Things You Need to Know
The statute forces disclosure of funding and reviewer involvement for non‑peer‑reviewed studies and requires agencies to publish those materials on the public docket unless exempt under FOIA.
A submission’s conflict triggers public disclosure if at least 10% of a study’s funding comes from an entity subject to the agency’s jurisdiction for that rulemaking, or if a regulated entity conducted, reviewed, or revised the research.
OMB/OIRA must complete review of a significant regulatory action within 60 days of receipt, with a single 30‑day extension allowed only with public written justification.
Entities that file annual reports under Section 13 of the Securities Exchange Act that knowingly submit materially false statements to an agency face civil penalties of at least $250,000 for a first violation and $1,000,000 for subsequent violations; offending submissions may be excluded from the record.
The bill creates an Office of the Public Advocate (Senate‑confirmed), charges it with conducting social equity assessments on request within 30 days, and requires agencies to maintain participation logs and expanded outreach procedures.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Mandatory disclosures for submitted studies
This provision inserts a new disclosure regime into §553(c). When an interested person submits a study or cites work they funded, the submitter must disclose the funds paid to the researcher, the funding entity, any entities that reviewed or revised the work, and financial relationships between the researcher and parties affected by the rule. Practically, commenters that have previously treated commissioned studies as proprietary will now have to include verifiable funding and reviewer information in the docket or risk exclusion.
Public posting, conflict tests, and exclusion authority
Agencies must post non‑peer‑reviewed submissions on the public docket and flag conflicts where funding thresholds or regulator involvement exist. The bill sets a numeric bright line (10% funding from an entity within the agency’s jurisdiction) and an alternative test based on regulator involvement. If submitters omit required disclosures, agencies may exclude or disregard the submission and decline to respond, though the submitter can resubmit with disclosures during the open comment period.
Record changes after OMB review and attribution
Agencies must place in the rulemaking docket the substance of any changes between drafts shared with OMB and the published notice or final rule, and state whether those changes were the result of communications with OMB, another agency, or any other Federal official. This creates a traceable paper trail of post‑draft edits tied to executive branch coordination and is designed to prevent opaque post‑draft modifications.
Justify withdrawn rules; permit fast‑track reinstatement
An agency that withdraws a regulatory action after providing it for centralized review must publish a detailed statement explaining the withdrawal and indicate whether it was based on requests or input from OMB, another agency, or federal officials. Separately, agencies can reinstate rules Congress previously disapproved by republishing them within one year of this Act; after that, ordinary §553 procedures apply for reinstatement.
Narrowing negotiated rulemaking to governments
The text narrows negotiated rulemaking language in subchapter III of chapter 5 to informal negotiations between federal, state, local, and tribal governments only — removing the statutory encouragement for agency use of negotiated rulemaking with broad stakeholder panels and deleting numerous statutory cross‑references that required negotiated rulemaking in preexisting laws.
60‑day OIRA clock with one 30‑day extension
The Office must complete review of a significant regulatory action within 60 days of receiving it; a single 30‑day extension is permitted only with a public written justification. If OIRA waives or misses the deadline, the agency may proceed to publish the regulatory action in the Federal Register.
Civil penalties and reporting obligations for public companies
Entities required to file annual SEC reports that knowingly submit materially false or misleading statements to agencies face minimum civil penalties and permanent exclusion of the offending submission from the administrative record; the bill also requires such filers to include recent SEC annual and quarterly reports with certain submissions.
New public advocate office and expanded public notice duties
Creates a Senate‑confirmed National Public Advocate within OMB to assist public participation, perform and publish social equity research, coordinate outreach with state/local/tribal partners, and issue rules within 180 days of appointment. Agencies must expand public notice of proposed and final rules, notify interested persons within two business days of publication, and maintain participation logs.
Broadened judicial deference, six‑year review window, and social equity requirements
Section 706 is amended to instruct courts to defer to reasonable agency statutory interpretations even for high‑significance rules if the agency followed required procedural steps; the bill also defines several categories of 'unreasonable delay.' It adds a new six‑year statute of limitations for judicial review of final agency actions and requires agencies performing cost‑benefit analyses to account for non‑quantifiable benefits and distributional/social equity impacts.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Communities historically underrepresented in rulemaking — the Office of the Public Advocate is charged with outreach, language access, and conducting social equity assessments, which can elevate previously sidelined concerns and produce docketed equity analyses for agency decision‑makers and courts.
- Public‑interest and consumer groups — greater transparency about who funded or reviewed technical studies improves their ability to rebut industry‑commissioned analyses and to call out potential conflicts in the administrative record.
- Agencies and rule drafters seeking defensible records — mandatory docketing of changes after OMB review and detailed withdrawal explanations create a clearer contemporaneous record that agencies can use to defend final rules in litigation.
Who Bears the Cost
- Think tanks, consultants, and industry trade associations that commission non‑peer‑reviewed studies — they must now disclose funders, reviewers, and contractual ties, creating administrative burden and potential commercial sensitivity concerns.
- Academic researchers and small research shops — the disclosure regime may deter some private funding relationships or require additional contract terms; institutions may face increased compliance and recordkeeping costs to support docketing obligations.
- Federal agencies and OMB — posting, cataloguing, and vetting disclosures, running faster OIRA timelines, conducting or coordinating social equity assessments, and servicing expanded public‑participation requirements will increase staff workload and may require additional resources to meet new deadlines.
Key Issues
The Core Tension
The central dilemma is between transparency/stability and robust, accessible participation: the bill forces greater public visibility into who funds and edits technical work (addressing agency capture and improving the administrative record) but does so in ways that could discourage legitimate research partnerships, impose heavy compliance costs on small researchers, and concentrate power in executive coordination (OMB) and agency discretion — achieving openness without chilling participation or undermining evidence production is the core trade‑off.
The bill tackles capture and secrecy by converting many commissioned technical submissions into public, attributed material. That objective creates trade‑offs.
Requiring disclosure of funders and reviewer involvement strengthens transparency but can chill partnerships where funders seek confidentiality, complicate collaboration with private research sponsors, and expose raw or preliminary data that may be protected by other statutes or contractual obligations. Agencies will have to reconcile competing legal duties when submitters assert confidentiality claims or trade‑secret protections under FOIA exemptions.
The legislation tilts the balance toward executive‑branch coordination and institutionalized equity review: mandating a 60‑day OIRA clock with limited extension compresses review windows and may push unresolved issues downstream into litigation or post‑promulgation corrections. Narrowing negotiated rulemaking to intergovernmental talks reduces one formal mechanism for multi‑stakeholder bargaining and shifts stakeholder influence into notice‑and‑comment and the new disclosure regime.
The combination of broader deference language in §706 and fewer procedural barriers to reintroducing previously disapproved rules raises separation‑of‑powers and accountability questions that could provoke judicial scrutiny.
Finally, the civil penalty regime targets public companies but may create uneven deterrence: nonprofits, individuals, and unregistered entities remain outside the penalty framework even though they may submit influential studies. Agencies will need to develop operational rules about how to vet disclosure accuracy, how to handle resubmissions, and how to resolve conflicts between disclosure obligations and other legal protections — practical implementation will determine whether the law increases clarity or simply relocates disputes into discovery and litigation.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.